EARNINGS AND TRADING: Allergy Therapeutics names next executive chair
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 1,622.00p on 05-08-2026 at 05:00:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 1,700.00p |
| Sell | 1,550.00p |
| Last Trade: | Unknown 2,237.00 at 1,622.00p |
| Day's Volume: | 0 |
| Last Close: | 1,622.00p |
| Open: | 0.00p |
| ISIN: | GB0000385517 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 812.00p - 1,676.00p |
| Market Capitalisation: | £309.93m |
| VWAP: | 0.00p |
| Shares in Issue: | 19.11m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Biotech Gwth (BIOG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 2,237 | 1,622.00p | OTC Trade |
17:07:19 - 04-Aug-26 |
| Sell* | 9,572 | 1,622.00p | Uncrossing Trade |
16:35:17 - 04-Aug-26 |
| Unknown* | 0 | 1,610.00p | SI Trade |
16:29:26 - 04-Aug-26 |
| Buy* | 52 | 1,612.1322p | Ordinary |
16:24:46 - 04-Aug-26 |
| Unknown* | 0 | 1,618.00p | SI Trade |
16:21:10 - 04-Aug-26 |
| Sell* | 4,250 | 1,610.319p | Ordinary |
16:20:12 - 04-Aug-26 |
| Buy* | 184 | 1,611.12p | Ordinary |
16:19:35 - 04-Aug-26 |
| Buy* | 3 | 1,618.00p | SI Trade |
16:18:56 - 04-Aug-26 |
| Buy* | 617 | 1,612.018p | Ordinary |
16:17:45 - 04-Aug-26 |
| Buy* | 20 | 1,618.00p | SI Trade |
16:11:38 - 04-Aug-26 |
Biotech Gwth (BIOG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 4th Aug 2026 1:42 pm | PRN | Net Asset Value(s) |
| 3rd Aug 2026 2:42 pm | PRN | Net Asset Value(s) |
| 3rd Aug 2026 10:20 am | PRN | Total Voting Rights |
| 3rd Aug 2026 8:30 am | PRN | Confirmation of Portfolio Management Arrangements |
| 31st Jul 2026 5:18 pm | PRN | Transaction in Own Shares |
| 31st Jul 2026 2:12 pm | PRN | Net Asset Value(s) |
| 30th Jul 2026 1:44 pm | PRN | Net Asset Value(s) |
| 29th Jul 2026 3:11 pm | PRN | Net Asset Value(s) |
| 28th Jul 2026 1:23 pm | PRN | Net Asset Value(s) |
| 28th Jul 2026 7:00 am | PRN | argenx SE to acquire BIOG portfolio company, Forte Biosciences, Inc |